Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,895 | 400 | 97.5% |
| Education | $230.29 | 4 | 2.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $1,257 | 68 | $0 (2024) |
| Myriad Genetic Laboratories, Inc. | $579.83 | 20 | $0 (2024) |
| Janssen Biotech, Inc. | $575.07 | 26 | $0 (2024) |
| ACCORD HEALTHCARE, INC. | $441.31 | 11 | $0 (2024) |
| PFIZER INC. | $436.47 | 27 | $0 (2024) |
| Boston Scientific Corporation | $370.87 | 10 | $0 (2023) |
| Antares Pharma, Inc. | $357.04 | 18 | $0 (2023) |
| Dendreon Pharmaceuticals LLC | $352.67 | 11 | $0 (2024) |
| Avadel Specialty Pharmaceuticals, LLC | $349.80 | 8 | $0 (2019) |
| Merck Sharp & Dohme LLC | $344.34 | 20 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,249 | 52 | Sumitomo Pharma America, Inc. ($181.74) |
| 2023 | $1,837 | 59 | Myriad Genetic Laboratories, Inc. ($304.85) |
| 2022 | $1,376 | 69 | Astellas Pharma US Inc ($174.40) |
| 2021 | $1,189 | 60 | Astellas Pharma US Inc ($261.06) |
| 2020 | $424.36 | 25 | Allergan, Inc. ($67.09) |
| 2019 | $805.70 | 48 | Janssen Biotech, Inc. ($119.56) |
| 2018 | $1,622 | 63 | Avadel Specialty Pharmaceuticals, LLC ($334.97) |
| 2017 | $622.08 | 28 | Valeant Pharmaceuticals North America LLC ($110.92) |
All Payment Transactions
404 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: ONCOLOGY | ||||||
| 12/17/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $21.58 | General |
| Category: Oncology | ||||||
| 12/13/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | YONSA (Drug) | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: Oncology | ||||||
| 12/12/2024 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $25.27 | General |
| Category: INTERVENTIONAL UROLOGY | ||||||
| 12/10/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: UROLOGY | ||||||
| 12/09/2024 | ACCORD HEALTHCARE, INC. | CAMCEVI (Drug) | Food and Beverage | In-kind items and services | $10.31 | General |
| Category: Oncology | ||||||
| 11/25/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $20.07 | General |
| Category: ONCOLOGY | ||||||
| 11/23/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: Oncology | ||||||
| 11/15/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $17.42 | General |
| Category: Oncology | ||||||
| 11/12/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $20.25 | General |
| Category: ONCOLOGY | ||||||
| 10/24/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $133.32 | General |
| Category: UROTHELIAL CANCER | ||||||
| 10/15/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: Oncology | ||||||
| 10/11/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $20.49 | General |
| Category: Oncology | ||||||
| 10/08/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $20.75 | General |
| Category: UROLOGY | ||||||
| 10/01/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: ONCOLOGY | ||||||
| 09/30/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), WELIREG | Food and Beverage | In-kind items and services | $26.42 | General |
| Category: ONCOLOGY | ||||||
| 09/17/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: UROLOGY | ||||||
| 09/06/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: Oncology | ||||||
| 09/03/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $22.49 | General |
| Category: ONCOLOGY | ||||||
| 08/30/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $18.39 | General |
| Category: Oncology | ||||||
| 08/20/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $12.72 | General |
| Category: UROLOGY | ||||||
| 08/13/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: Oncology | ||||||
| 08/06/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: ONCOLOGY | ||||||
| 07/29/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $27.83 | General |
| Category: Oncology | ||||||
| 07/26/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $21.03 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 2,047 | 5,661 | $643,143 | $159,772 |
| 2022 | 28 | 2,230 | 6,711 | $600,715 | $173,856 |
| 2021 | 26 | 2,180 | 8,921 | $669,076 | $209,836 |
| 2020 | 33 | 2,677 | 8,050 | $663,714 | $175,457 |
All Medicare Procedures & Services
115 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 465 | 549 | $135,461 | $31,651 | 23.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 275 | 348 | $113,566 | $30,011 | 26.4% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 15 | 144 | $100,800 | $18,902 | 18.8% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 69 | 344 | $43,688 | $16,582 | 38.0% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 64 | 91 | $65,955 | $14,739 | 22.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 88 | 88 | $34,272 | $9,842 | 28.7% |
| 99426 | Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 40 | 150 | $18,750 | $7,091 | 37.8% |
| 74178 | Ct scan of abdomen and pelvis before and after contrast | Office | 2023 | 17 | 17 | $14,188 | $4,573 | 32.2% |
| 55700 | Biopsy of prostate gland | Office | 2023 | 24 | 24 | $15,511 | $4,298 | 27.7% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 32 | 36 | $13,148 | $3,743 | 28.5% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 46 | 88 | $8,448 | $3,212 | 38.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 306 | 367 | $5,505 | $3,074 | 55.8% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 18 | 21 | $23,752 | $2,129 | 9.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 21 | 21 | $7,536 | $2,124 | 28.2% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 213 | 262 | $9,907 | $1,939 | 19.6% |
| 51700 | Simple bladder irrigation and/or instillation | Office | 2023 | 16 | 21 | $4,882 | $1,111 | 22.8% |
| 55700 | Biopsy of prostate gland | Facility | 2023 | 11 | 11 | $7,701 | $1,098 | 14.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 13 | 13 | $3,985 | $925.44 | 23.2% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 18 | 29 | $2,972 | $729.12 | 24.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 15 | 15 | $2,538 | $652.17 | 25.7% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 106 | 122 | $1,464 | $379.42 | 25.9% |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 2023 | 25 | 2,641 | $2,509 | $299.85 | 12.0% |
| 76872 | Ultrasound scan of pelvic region through rectum | Facility | 2023 | 11 | 11 | $5,190 | $274.78 | 5.3% |
| 81003 | Automated urinalysis test | Office | 2023 | 89 | 98 | $980.00 | $215.60 | 22.0% |
| 82565 | Blood creatinine level | Office | 2023 | 25 | 25 | $300.00 | $125.50 | 41.8% |
About Dr. John Mccarthy, MD
Dr. John Mccarthy, MD is a Urology healthcare provider based in Chesterfield, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/29/2006. The National Provider Identifier (NPI) number assigned to this provider is 1477662179.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Mccarthy, MD has received a total of $9,126 in payments from pharmaceutical and medical device companies, with $1,249 received in 2024. These payments were reported across 404 transactions from 60 companies. The most common payment nature is "Food and Beverage" ($8,895).
As a Medicare-enrolled provider, Mccarthy has provided services to 9,134 Medicare beneficiaries, totaling 29,343 services with total Medicare billing of $718,921. Data is available for 4 years (2020–2023), covering 115 distinct procedure/service records.
Practice Information
- Specialty Urology
- Other Specialties Urology
- Location Chesterfield, MO
- Active Since 08/29/2006
- Last Updated 12/01/2021
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1477662179
Products in Payments
- XTANDI (Drug) $651.30
- PROVENGE (Drug) $463.59
- CAMCEVI (Drug) $441.31
- PROLARIS (Device) $423.27
- Myrbetriq (Drug) $384.08
- GEMTESA (Drug) $370.79
- Noctiva (Drug) $349.80
- KEYTRUDA (Biological) $312.59
- BOTOX (Biological) $307.69
- ERLEADA (Drug) $285.06
- Erleada (Drug) $271.26
- MYRBETRIQ (Drug) $251.29
- Nubeqa (Drug) $206.17
- TRADE PROMO: SPIES FLEXC, US DEFL (Device) $199.85
- NOCDURNA (Drug) $183.92
- LITHOVUE (Device) $169.51
- Prolaris (Device) $156.56
- JELMYTO (Drug) $156.06
- ORGOVYX (Drug) $147.51
- Lupron (Drug) $130.96
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Chesterfield
Dr. Cathy Naughton, Md, MD
Urology — Payments: $30,035
David Bryan, Md, MD
Urology — Payments: $23,173
Steven Schneider, Md, MD
Urology — Payments: $6,247
Nimrod Barashi Gozal, Md, MD
Urology — Payments: $4,667
Mrs. Angela Alt, Md, MD
Urology — Payments: $139.03
Ronald Deguerre, Md, MD
Urology — Payments: $49.96